Dr. Bertalan Mesko, PhD, known as The Medical Futurist, is the Director of The Medical Futurist Institute. He specializes in analyzing the impact of science fiction technologies on global medicine and healthcare.

As a geek physician with a PhD in genomics, he is also an Amazon Top 100 author and serves as a Private Professor at Semmelweis Medical School in Budapest, Hungary.

Dr. Mesko has delivered over 900 keynotes at prestigious institutions such as Harvard, Stanford, and Yale Universities, as well as organizations like the WHO and the world's top 10 pharmaceutical companies. His insights on healthcare technology have made him a leading global voice in the field.

Featured by major media outlets including CNN, National Geographic, Forbes, TIME magazine, BBC, and the New York Times, Dr. Mesko regularly shares his analyses on medicalfuturist.com.

His research focuses on the role of artificial intelligence and digital health technologies in shaping the future of care. He is a member of the "Committee on Future Research" of the Hungarian Academy of Sciences.

Dedicated to pioneering medical futures studies as a scientific discipline, Dr. Mesko aims to make futures methods widely accessible in healthcare.

He is a Certified Superforecaster for Good Judgment, Inc.

Bertalan Meskó

This is the amount of paperwork required to admit a patient to a hospital in the United Kingdom!

It’s basically a “paper patient twin.”

For an experienced staff, it would take roughly ~90 minutes of documentation on paper.

Or as part of traditional EHR workflows, around ~35–45 minutes and 600–800 clicks!

Or about 15 minutes and 20-40 clicks using an AI scribe.

Just my subjective estimations.

That means AI could reduce documentation time by roughly 70% compared to paper, and reduce click burden by around 95% compared to conventional EHR systems. Significantly lowering cognitive load and fragmentation would be the added bonus.

What are hospitals waiting for?

Bertalan Meskó, MD, PhD

The Medical Futurist, Author of Your Map to the Future, Global Keynote Speaker, and Futurist Researcher

No alternative text description for this image

What is "digital blood testing"?

The idea is that using wearable patches makes it possible to measure medication levels in blood without taking blood samples.

"In a pilot trial – the findings of which have been published in Nature Biotechnology – the patch was used to monitor levels of vancomycin, a last-resort antibiotic that was said to have always been tricky to dose.
 
The patch, which is reportedly more comfortable than standard blood draws, uses synthetic DNA-based sensors, called aptamers, to measure dosage levels."

It would be a game-changer in so many areas from chronic disease management and at-home care to drug monitoring and precision health!

More on this: https://lnkd.in/djYHdBtM

This is a handheld X-ray from KnovelCam. 

Lightweight, portable, and works right at the bedside!

But it triggered a bigger question: What happens when powerful medical technologies become too accessible?

When technology becomes:
• smaller
• cheaper
• easier to use
• directly accessible to patients

Then it changes human behavior.

With handheld imaging devices, the risk is overuse, unnecessary scans, and people underestimating radiation exposure because the device "looks harmless".

We’ve already seen similar behavioral shifts with:
• Continuous glucose monitors used without medical indication
• Direct-to-consumer genetic tests interpreted without context
• Full-body MRI scans marketed as preventive screening
• Health wearables creating anxiety from perfectly normal data

So what other digital health and medical technology comes to mind that you think patients will definitely abuse?

Digital Health and Corporate Innovation Executive | Independent Consultant working with Startups and Corporate | ex-Novartis BIOME co-founder | Startup Investor, Advisor & Mentor | Founder of #GenAI4Pharma

► AI & Digital Innovation Leader | Biopharma Executive | Startup Advisor & Investor
→ I help biopharma companies navigate and lead the future of healthcare through AI, digital strategy, and innovation. 
→ With nearly 20 years of experience across commercial, clinical, and enterprise functions, I’ve held senior leadership roles at top pharma companies, including BMS, Novartis, and Biogen.
→ Most recently, I served as VP and Head of Global Digital Strategy at Bristol Myers Squibb, where I was accountable to the Executive Leadership Team and Board of Directors for driving enterprise-wide digital innovation. Prior to that, I was a founding member of the Novartis BIOME, a global network of digital innovation hubs.

► Keynote Speaker & Workshop Facilitator | Trusted by Pharma & MedTech Leaders
→ I work as a strategic advisor, speaker, and fractional executive for startups and corporate teams. 
→ I regularly deliver keynotes and executive workshops to help pharma and medtech leaders integrate Generative AI and corporate innovation into their strategy, operations, and organizational culture.
→ As the founder of #GenAI4Pharma, I lead a global event series spotlighting AI’s impact across the biopharma value chain—from discovery to commercialization.

► Deep Roots in the Health Tech Ecosystem
→ I’ve been an early advisor, investor and/or mentor to 30+ healthtech startups and innovation programs, including:
→ Accelerators & VCs: SignalFire AI Lab, Redesign Health, PharmStars, Springboard
→ Startups: OmniScience, Compose Health, Peer AI, Sidekick Health, ReachRx, ZoomLogi
→ Advisory Boards: Google Health, MM+M Transformers, SXSW, GRYT Health, Digital Health Coalition

I’ve also co-led global healthcare hackathons through MIT Hacking Medicine, and continue to champion cross-industry collaboration between pharma and digital health innovators.

► Speaking & Media Recognition
→ Named a Top 40 Healthcare Transformer by MM&M and recognized multiple times by PRWeek, Constellation Research, and Medika Life, I’m a frequent speaker at global conferences and a contributor to thought leadership events and articles on healthcare innovation and AI.

► Let’s connect if you’re exploring how to:
→ Embed GenAI into your biopharma strategy
→ Design innovation programs with real business impact
→ Partner with startups to accelerate transformation

taplio

The Battle

Bertalan Meskó

Shwen Gwee

Followers

Posts

Engagements

Likes

Performance ScoreBertalan Meskó's LinkedIn Performance

Ready to grow your LinkedIn presence?

taplio

The Battle

Bertalan Meskó

Shwen Gwee

Followers

Posts

Engagements

Likes

Performance Score.css-goub6s{font-size:var(--chakra-fontSizes-md);font-weight:500;color:var(--chakra-colors-gray-600);display:block;margin-top:var(--chakra-space-1);}Bertalan Meskó's LinkedIn Performance

Ready to grow your LinkedIn presence?

Performance ScoreBertalan Meskó's LinkedIn Performance